Patient recruitment is the single biggest bottleneck in clinical research. Industry data consistently shows that 80 percent of trials miss their enrollment deadlines, and failed recruitment is responsible for the majority of trial delays and cancellations. Yet many sites still rely on outdated, single-channel approaches that simply cannot deliver the participant volumes modern trials require. At MD Trials, we have helped sites across Canada transform their enrollment performance using a multi-layered, data-informed recruitment model. Here are seven strategies that deliver real results.
Strategy 1: Build a Pre-Trial Patient Database
Sites that maintain a living registry of pre-screened, consented patients interested in research participation consistently outperform reactive recruitment models. MD Trials helps sites build and maintain proprietary patient databases segmented by therapeutic area, demographics, and medical history — creating an instant pipeline the moment a new study activates.
Strategy 2: Leverage Digital Advertising with Precision Targeting
Social media and search advertising allow hyper-specific demographic and geographic targeting. Facebook, Instagram, and Google Ads can reach patients actively searching for treatment options — at a fraction of traditional advertising costs. MD Trials manages compliant digital campaigns that generate pre-screened referrals directly into site workflows.
Strategy 3: Physician and Community Referral Networks
Building trust with referring physicians and community health organisations generates a steady, high-quality referral stream. MD Trials facilitates outreach to family physicians, specialists, pharmacists, and patient advocacy groups relevant to each therapeutic area.
Strategy 4: Streamline the Screening Process
Complex, time-consuming screening drives away eligible patients. Simplified online pre-screening tools and responsive scheduling dramatically improve conversion rates. MD Trials designs patient-friendly intake processes that reduce friction while maintaining protocol integrity.
Strategy 5: Prioritise Retention from Day One
Recruiting patients is only half the battle — keeping them is the other. MD Trials implements structured retention programs including regular check-ins, transportation support, clear visit scheduling, and dedicated participant coordinators who build trust throughout the study.
Strategy 6: Use Electronic Medical Record Searches
EMR-based cohort identification allows sites to identify eligible patients within their existing patient population instantly. MD Trials works with site investigators to conduct ethical, approved EMR reviews that surface study candidates efficiently.
Strategy 7: Measure, Analyse, and Adjust in Real Time
Recruitment strategies that are not measured cannot be improved. MD Trials tracks referral sources, conversion rates, dropout patterns, and screening outcomes in real time — allowing rapid campaign adjustments that keep enrollment on track.
“Sites using multi-channel digital recruitment achieved enrollment timelines up to 40 percent faster than sites relying on traditional physician referrals alone.”
— Journal of Clinical Research Best Practices
Frequently Asked Questions
How long does patient recruitment typically take for a Phase II trial?
Timelines vary by therapeutic area and protocol complexity, but Phase II trials commonly take 6–18 months for full enrollment. With optimised multi-channel recruitment, MD Trials helps sites significantly compress this window.
Is digital advertising for clinical trials compliant with regulations?
Yes, when properly managed. MD Trials ensures all digital recruitment materials are reviewed and approved by the study’s Ethics Board before launch, in full compliance with Health Canada and GCP guidelines.
What is the most common reason patients drop out of clinical trials?
The top reasons include inconvenient visit schedules, lack of communication, and feeling undervalued. MD Trials’ retention programs directly address all three with structured touchpoints and participant support.
No comment